MONUROL
FOSFOMYCIN TROMETHAMINE
Approval overview MONUROL is listed in Drugs@FDA under application 050717 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient FOSFOMYCIN TROMETHAMINE Form and strength FOR SOLUTION;ORAL - EQ 3GM BASE/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ZAMBON SPA Submission history Latest submission status date: 2018-11-12 00:00:00.
Structured Monograph
Clinical summary
Approval overview MONUROL is listed in Drugs@FDA under application 050717 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FOSFOMYCIN TROMETHAMINE Form and strength FOR SOLUTION;ORAL - EQ 3GM BASE/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ZAMBON SPA Submission history Latest submission status date: 2018-11-12 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.